Diagnostic concordance of GeneXpert HCV VL fingerstick and GeneXpert HCV viral load with RT-PCR in POCT settings among hemodialysis patients
Open Access
- 13 February 2026
- journal article
- microbiology
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0324671
Abstract
Background: Hepatitis C virus (HCV) remains a significant global health concern, particularly among high-risk populations such as patients undergoing hemodialysis. Although nucleic acid testing (NAT) using RT-PCR remains the gold standard for HCV RNA detection, its centralized laboratory workflow limits accessibility. Point-of-care molecular testing (PoCT), such as the GeneXpert Fingerstick assay, offers a decentralized alternative for HCV RNA quantification. However, its analytical concordance with reference methods in Indonesian settings remains limited. Methods: This study was a cross-sectional analytical concordance study involving 57 patients with chronic kidney disease (CKD) undergoing hemodialysis at Cipto Mangunkusumo and Pelni Hospitals in Jakarta. Each participant underwent HCV RNA testing using three methods: GeneXpert HCV VL Fingerstick, GeneXpert HCV VL Plasma, and Cobas TaqMan RT-PCR (as the reference standard). Agreement among methods was assessed using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and Cohen’s κ coefficient. Correlation for quantifiable values was evaluated using linear regression analysis. Results: Both GeneXpert methods showed perfect concordance with the Cobas TaqMan RT-PCR, with sensitivity, specificity, PPV, and NPV all at 100%. Agreement analysis yielded a Cohen’s κ of 1.000 ( p < 0.001) for both comparisons. Quantitative correlation between methods was also strong ( R² > 0.95). Conclusion: The GeneXpert HCV VL Fingerstick assay demonstrates excellent analytical agreement with conventional molecular testing and may serve as a simple, practical, decentralized alternative for monitoring HCV RNA in hemodialysis patients.Keywords
This publication has 17 references indexed in Scilit:
- The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysisJournal Of Nephrology, 2022
- Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, SpainInternational Journal of Drug Policy, 2020
- In‐field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in TanzaniaLiver International, 2019
- Point‐of‐care HCV RNA testing in the setting of DAA therapy: HCV‐FiS (HEpatitis C Virus Fingerstick Study)Liver International, 2019
- The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimensJournal of Clinical Virology, 2019
- Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in CambodiaJournal of Viral Hepatitis, 2018
- Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care AssayThe Journal of Infectious Diseases, 2018
- Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort studyThe Lancet Gastroenterology & Hepatology, 2017
- Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, RwandaBioMed Research International, 2017
- APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testingHepatology International, 2016